Accretion Nutraveda Limited (BOM:544694)
India · Delayed Price · Currency is INR 286.00
+9.00 (3.25%)
At close: Aug 21, 2026
Accretion Nutraveda Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 97.45 | 0.15 | 1.19 | 0.86 | 0.44 |
Cash & Short-Term Investments | 97.45 | 0.15 | 1.19 | 0.86 | 0.44 |
Cash Growth | 63178.57% | -87.06% | 38.21% | 93.88% | - |
Accounts Receivable | 81.12 | 32.67 | 2.5 | 8 | 5.4 |
Other Receivables | 14.64 | 2.57 | 3.6 | 3.23 | 3.18 |
Receivables | 95.76 | 35.31 | 6.13 | 11.24 | 8.58 |
Inventory | 89.95 | 45.9 | 23.8 | 12.95 | 3.4 |
Other Current Assets | 19.49 | 5.63 | 1.41 | 0.66 | 0.87 |
Total Current Assets | 302.64 | 87.01 | 32.53 | 25.71 | 13.29 |
Property, Plant & Equipment | 16.56 | 18.32 | 13.86 | 14.89 | 17.95 |
Long-Term Deferred Tax Assets | 0.04 | 0.07 | - | - | - |
Other Long-Term Assets | 98.56 | - | 0 | - | - |
Total Assets | 417.8 | 105.39 | 46.39 | 40.6 | 31.24 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 6.59 | 8.43 | 8.02 | 16.03 | 7.15 |
Accrued Expenses | 1.35 | 0.47 | 0.64 | 0.13 | 0 |
Short-Term Debt | - | 13.98 | 14.97 | 4.37 | - |
Current Portion of Long-Term Debt | 4.47 | - | 1.66 | 1.66 | 1.38 |
Current Income Taxes Payable | 11.08 | 5.37 | 1.01 | - | - |
Other Current Liabilities | 1.78 | 2.01 | 4.06 | 1.92 | 0.01 |
Total Current Liabilities | 25.26 | 30.27 | 30.35 | 24.11 | 8.55 |
Long-Term Debt | 37.82 | 24.61 | 5.11 | 13.7 | 22.78 |
Pension & Post-Retirement Benefits | - | - | 0.01 | 0 | - |
Long-Term Deferred Tax Liabilities | - | - | 0.07 | 0.16 | 0.15 |
Other Long-Term Liabilities | - | - | 0 | -0 | - |
Total Liabilities | 63.07 | 54.87 | 35.54 | 37.97 | 31.48 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 72.4 | 4.87 | 3.6 | 3.6 | 3.6 |
Additional Paid-In Capital | 228.48 | 15.24 | - | - | - |
Retained Earnings | 53.85 | 30.41 | 7.25 | -0.97 | -3.84 |
Shareholders' Equity | 354.73 | 50.52 | 10.85 | 2.63 | -0.24 |
Total Liabilities & Equity | 417.8 | 105.39 | 46.39 | 40.6 | 31.24 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 42.28 | 38.59 | 21.74 | 19.73 | 24.16 |
Net Cash (Debt) | 55.17 | -38.43 | -20.55 | -18.87 | -23.72 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 10.18 | -10.58 | -5.71 | -5.24 | -0.07 |
Filing Date Shares Outstanding | 7.24 | 5.32 | 3.6 | 3.5 | 3.6 |
Total Common Shares Outstanding | 7.24 | 4.87 | 3.6 | 3.5 | 3.6 |
Working Capital | 277.38 | 56.74 | 2.19 | 1.6 | 4.74 |
Book Value Per Share | 49.00 | 10.37 | 3.01 | 0.75 | -0.07 |
Tangible Book Value | 354.73 | 50.52 | 10.85 | 2.63 | -0.24 |
Tangible Book Value Per Share | 49.00 | 10.37 | 3.01 | 0.75 | -0.07 |
Buildings | 3.3 | 3.26 | 2.05 | 2.05 | 2.05 |
Machinery | 25.34 | 24.54 | 18.26 | 17.69 | 17.64 |
Construction In Progress | - | - | 1.01 | - | - |